Important matters:
Cully Pharmaceutical-B (01672): GLP-1 oral administration of the small molecule ASC30 achieved a 1.7% reduction in placebo-corrected glycated hemoglobin (HbA1c) at week 12 of the US Phase II study in diabetic subjects
Junshi Biotech (01877): Treplimumab has received routine approval from the State Drug Administration for the treatment of locally advanced or metastatic urothelial cancer where platinum-containing chemotherapy fails
Boleyton (01333) and Jin Chengjian intend to establish a long-term cooperative relationship in the field of green energy and intelligent mining industry collaboration in the Democratic Republic of the Congo (DRC)
Hengrui Pharmaceutical (01276): HRS-8046 tablets approved for clinical trials
Cathay Pacific Haitong (02611) subsidiary approved to establish Shanghai Pilot Science and Technology Innovation Fund Partnership (Limited Partnership)
A subsidiary of Xiehe New Energy (00182) plans to sell 100% of the shares in Gail Mountain and Grape Creek for up to about US$29.98 million
Shiyao Group (01093): Phase I clinical trial of SYS6077 injection for the treatment of advanced malignant tumors officially launched at the first research center in China
Operating performance:
Jiangxi Copper Co., Ltd. (00358) net profit of 11.687 billion yuan in the first three quarters increased 94.02% year-on-year
Hop Sang Creative Development Group (00754) announced its 2025 results, with losses attributable to shareholders of HK$11.741 billion
Taobo (06110) announced interim results. Shareholders should account for 663 million yuan in profit, increasing the new brand matrix to expand the incremental space
The net profit of CNPC shares (00857) in the first three quarters was 155.776 billion yuan, up 21.9% year on year
Howell Group (00501) expects revenue of 7.759 billion yuan to 8.324 billion yuan in the fourth quarter, up 9.71% to 17.71% year-on-year
ASIX Technology (01675)'s revenue in the first three quarters was about 3.38 billion yuan, and the amount of non-operator market order contracts doubled
CGN Power (01816)'s net profit for the first three quarters was about 9.603 billion yuan, an increase of 12.75% over the previous year
Ping An of China (02318), net profit of 96.645 billion yuan in the first three quarters continued to deepen the development of a “comprehensive finance+medical care” two-wheel parallel, technology-driven strategy
China Taibao (02601)'s net profit for the first three quarters of 36.403 billion yuan decreased by 20.3% year-on-year
Standard Chartered Group (02888) announces third quarter results, profit before tax of US$2.3 billion increased 29% year over year
China Overseas Development (00688) had revenue of 13.4 billion yuan and operating profit of 14.49 billion yuan in the first three quarters